Design and Evaluation of Multiregional Trials with Heterogeneous Treatment Effect Across Regions

REFERENCES

• Caraco , Y. ( 2004 ). Genes and the response to drugs . New England Journal of Medicine 351 ( 27 ): 2867 – 2869 .
   PubMed Web of Science ®Google Scholar
• DerSimonian , R. , Laird , N. ( 1986 ). Meta-analysis in clinical trials . Controlled Clinical Trials 7 : 177 – 188 .
   PubMedGoogle Scholar
• Eichelbaum , M. , Spannbrucker , N. , Steincke , B. , Dengler , H. J. ( 1979 ). Defective N-oxidation of sparteine in man: A new pharmacogenetic defect . European Journal of Clinical Pharmacology 16 : 183 – 187 .
   PubMed Web of Science ®Google Scholar
• Fukuoka , M. , Yano , S. , Giaccone , G. , Tamura , T. , Nakagawa , K. , Douillard , J. Y. , Nishiwaki , Y. , Vansteenkiste , J. , Kudoh , S. , Rischin , D. , Eek , R. , Horai , T. , Noda , K. , Takata , I. , Smit , E. , Auerbach , S. , Macleod , A. , Feyereislova , A. , Dong , R. P. , Baselga , J. ( 2003 ). Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) . Journal of Clinical Oncology 21 : 2237 – 2246 .
   PubMed Web of Science ®Google Scholar
• Hartung , J. ( 1999 ). An alternative method for meta-analysis . Biometrical Journal 41 ( 8 ): 901 – 916 .
   Web of Science ®Google Scholar
• Hung , H. M. J. , Wang , S. J. , O'Neill , R. ( 2010 ). Consideration of regional difference in design and analysis of multi-regional trials . Pharmaceutical Statistics . doi: 10.1002/ pst.440
   Google Scholar
• International Conference on Harmonisation . ( 1998 ). Tripartite Guidance E5, Ethnic factors in the acceptability of foreign data . Federal Register 83 : 31790 – 31796 .
   Google Scholar
• International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use . ( 2006 ). Q&A for the ICH E5 Guideline on Ethnic Factors in the Acceptability of Foreign Data. http://www.ich.org/LOB/media/MEDIA 1194.pdf
   Google Scholar
• Kawai , N. , Stein , C. , Komiyama O., Li , Y. ( 2008 ). An approach to rationalize partitioning sample size into individual regions in a multiregional trial . Drug Information Journal 42 : 139 – 147 .
   Web of Science ®Google Scholar
• Ko , F. S. , Tsou , H. H. , Liu , J. P. , Hsiao , C. F. ( 2010 ). Sample size determination for a specific region in a multi-regional trial . Journal of Biopharmaceutical Statistics 20 : 870 – 885 .
   PubMed Web of Science ®Google Scholar
• Mahgoab , A. , Idle , J. R. , Dring , L. G. , Lancaster , R. , Smith , R. L. ( 1977 ). Polymorphic hydroxylation of debrisoquine in man . Lancet 2 : 584 – 586 .
   PubMed Web of Science ®Google Scholar
• Ministry of Health, Labor, and Welfare of Japan . ( 2007 ). Basic Principles on Global Clinical Trials . Tokyo : MHLW .
   Google Scholar
• Quan , H. , Zhao , P. L. , Zhang , J. , Roessner , M. , Aizawa , K. ( 2010 ). Sample size considerations for Japanese patients in a multi-regional trial based on MHLW guidance . Pharmaceutical Statistics 9 : 100 – 112 .
   PubMed Web of Science ®Google Scholar
• Uesaka , H. ( 2009 ). Sample size allocation to regions in a multiregional trial . Journal of Biopharmaceutical Statistics 19 : 580 – 594 .
   PubMed Web of Science ®Google Scholar
• Whitehead , A. ( 2002 ). Meta-Analysis of Controlled Clinical Trials . New York , NY : Wiley .
   Google Scholar